Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
OMA1 mediates local and global stress responses against protein misfolding in CHCHD10 mitochondrial myopathy
Mario K. Shammas, … , Joanna Poulton, Derek P. Narendra
Mario K. Shammas, … , Joanna Poulton, Derek P. Narendra
Published June 14, 2022
Citation Information: J Clin Invest. 2022;132(14):e157504. https://doi.org/10.1172/JCI157504.
View: Text | PDF
Research Article Cell biology Genetics

OMA1 mediates local and global stress responses against protein misfolding in CHCHD10 mitochondrial myopathy

  • Text
  • PDF
Abstract

Mitochondrial stress triggers a response in the cell’s mitochondria and nucleus, but how these stress responses are coordinated in vivo is poorly understood. Here, we characterize a family with myopathy caused by a dominant p.G58R mutation in the mitochondrial protein CHCHD10. To understand the disease etiology, we developed a knockin (KI) mouse model and found that mutant CHCHD10 aggregated in affected tissues, applying a toxic protein stress to the inner mitochondrial membrane. Unexpectedly, the survival of CHCHD10-KI mice depended on a protective stress response mediated by the mitochondrial metalloendopeptidase OMA1. The OMA1 stress response acted both locally within mitochondria, causing mitochondrial fragmentation, and signaled outside the mitochondria, activating the integrated stress response through cleavage of DAP3-binding cell death enhancer 1 (DELE1). We additionally identified an isoform switch in the terminal complex of the electron transport chain as a component of this response. Our results demonstrate that OMA1 was critical for neonatal survival conditionally in the setting of inner mitochondrial membrane stress, coordinating local and global stress responses to reshape the mitochondrial network and proteome.

Authors

Mario K. Shammas, Xiaoping Huang, Beverly P. Wu, Evelyn Fessler, Insung Y. Song, Nicholas P. Randolph, Yan Li, Christopher K.E. Bleck, Danielle A. Springer, Carl Fratter, Ines A. Barbosa, Andrew F. Powers, Pedro M. Quirós, Carlos Lopez-Otin, Lucas T. Jae, Joanna Poulton, Derek P. Narendra

×

Figure 11

OMA1 activation shapes the mitoproteome through mitonuclear signaling.

Options: View larger image (or click on image) Download as PowerPoint
OMA1 activation shapes the mitoproteome through mitonuclear signaling.
(...
(A) Left: Volcano plot of protein fold change (FC) in 36-week-old C10G58R versus C10WT mouse heart mitochondria quantified by label-free mass spectrometry (n = 4 mice per group). Right: Protein fold change versus transcript fold change in C10G58R versus C10WT mouse hearts. The proteomics data are from 36-week-old C10G58R versus C10WT mice on the WT background, and the transcriptomics data are from 14-week-old C10G58R versus C10WT littermates on the OMA1+/– background. (B) Validation of some proteins that were significantly upregulated or downregulated in the C10G58R versus C10WT proteomics data set. Immunoblot of C10WT, C10G58R, and C10S59L mouse heart lysates. Loading controls are shown in Supplemental Figure 14A. #Nonspecific band. (C) Immunoblot of heart lysates from 33-week-old C10G58R mice on the OMA1+/– background treated with a nontargeting control ASO or an OMA1 ASO. Loading controls are shown in Supplemental Figure 14B. #Nonspecific band. Error bars represent the SEM. *P < 0.05, **P < 0.01, and ***P < 0.001, by permutation-based FDR with s0 = 0 (A), 1-way ANOVA with Dunnett’s T3 multiple comparisons (B), and multiple t tests with Welch’s correction and correction for multiple comparisons with the 2-stage step-up (Benjamini, Krieger, and Yekutieli) method (C). See also Supplemental Figure 14 and Supplemental data set 2.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts